Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model
© BioMed Central Ltd. 2011
Published: 29 December 2011
The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and manipulated through microinjection, chemical treatment, and mutagenesis. These procedures have contributed to large-scale chemical, suppressor, and genetic screens to identify hematopoietic gene mutations. Genomic conservation and local synteny between the human and zebrafish genomes make genome-scale and epigenetic analysis of these mutations (by microarray, chromatin immunoprecipitation sequencing, and RNA sequencing procedures) powerful methods for translational research and medical discovery. In addition, large-scale screening techniques have resulted in the identification of several small molecules capable of rescuing hematopoietic defects and inhibiting disease. Here, we discuss the contributions of the zebrafish model to the understanding of hematopoiesis, hematopoietic stem cell development, and disease-related discovery. We also highlight the recent discovery of small molecules with clinical promise, such as dimethyl prostaglandin E2, 3F8, and thiazole-carboxamide 10A.
KeywordsChemical screen, disease fate mapping hematopoiesis HSCs morpholino mutagenesis suppressor screen transplantation zebrafish
A versatile model for genome-scale research
Advantages of the zebrafish model
Externally fertilized, transparent embryos
Visualization (fluorescence or morphologic screening); manipulation (morpholino, DNA, RNA injection)
Blood circulation by 23-26 hpf
Rapid initiation of hematopoiesis
Sexual maturity at 3 months
Short generation time for increased genetic manipulation and transgenic development
Large clutch size (100-200 embryos per pair or 10,000+ embryos per mass mating)
Increased likelihood of success for low probability genetic crosses/transgenic development; massive clutches of synchronized embryos make large-scale screening protocols possible
Conserved hematopoietic system
Relevant model for comparison with human/mammalian systems
Fluorescent and confocal microscopy procedures
Increased visual resolution resulting in greater potential for hematopoietic fate mapping
Transplantable kidney marrow
Ability to perform competitive transplantation assays screening for molecules capable of enhancing HSC development and engraftment and hematopoiesis
Here, we highlight the advantages of the zebrafish model through discussion of promising findings in the hematopoietic field with an emphasis on disease definition and management. In particular, we evaluate mutagenesis, gene knockdown, and screening in the zebrafish. These techniques have led to the discovery of several molecules and gene targets with therapeutic potential, including Tif1gamma, dimethyl prostaglandin E2 (dmPGE2), 3F8, and thiazole-carboxamide 10A. Furthermore, we highlight recent advances in the understanding of blood diseases, such as T-cell acute lymphoblastic leukemia (T-ALL) and hypochromic anemia.
The zebrafish shows genetic similarity to other vertebrates. At approximately 1.8 billion base pairs, the zebrafish genome is about two-thirds the size of the human genome . Although the fish genome is vastly rearranged, several areas of local synteny and some larger chromosomal regions are preserved . This has greatly facilitated positional cloning projects, as chromosomal synteny can be used as a guide within the genome. Comparisons of chromosomal arrangements and individual DNA sequences in the zebrafish have revealed general conservation, particularly for the Hox loci . However, the zebrafish genome incurred a significant duplication that arose in teleosts about 300 million years ago. Because of the early incidence of this duplication in teleost evolution, the zebrafish genome has since undergone further alterations as subsequent deletions are believed to have removed many of the originally duplicated genes . These genomic events are demonstrated by the presence of seven Hox clusters in zebrafish compared with only four in humans .
These alterations have provided unique opportunities for discovery, as they have sometimes led to a splitting of regulatory elements. For instance, the zebrafish has two independent transferrin receptor-1 genes . One is a general, ubiquitously expressed gene and the other is a red-blood-cell-specific gene. In humans, there is a single gene for transferrin receptor-1 that is expressed both highly in red blood cells and ubiquitously at a low level. Nevertheless, an independent zebrafish mutant in transferrin receptor-1 has been isolated that lacks red blood cells. Comparative genomic analysis and study of the regulatory sequences in this mutant may prove useful.
Recent technological advances have also made zebrafish epigenetic analysis possible, as demonstrated by the use of chromatin immunoprecipitation sequencing (ChIP-seq) by a number of laboratories studying specific chromatin or transcription factor binding in whole zebrafish embryos [14, 15]. Furthermore, chromatin remodeling has been evaluated by analyzing specific histone modifications, such as methylation and acetylation. Recent studies have highlighted the specific post-translational modifications H3K4me3, H3K9ac, and H4ac as activating; H3K27me3 and H3K9me3 as repressing; and H3K36me3 as being involved in transcriptional elongation [16, 17]. Through these techniques, the zebrafish model has helped to clarify the relationship between epigenetics and gene function, and can be expected to further contribute to this understanding in the future.
Using the zebrafish model for gene/protein or small-molecule discovery relevant to human blood disorders
Zebrafish mutant (protein or small molecule)
Human disorder or potential therapeutic application
Assembly of Fe-S cluster†‡
Dimethyl prostaglandin E2
Bone marrow transplant therapy (clinical trial)
Enhanced HSC engraftment†
GSK3 implicated in type II diabetes, bipolar disorder, Alzheimer's disease, some cancers
PLK1 upregulated in many cancers
Other large-scale approaches have been applied to the zebrafish system. One uses 'targeting-induced local lesions in genomes' (TILLING), a process by which random mutagenesis and individual exon sequencing are carried out to identify mutations within a particular gene, essentially mimicking the outcome of targeted mutagenesis . This approach has led to the derivation of mutants in the runx1 and gata1 genes, which encode transcription factors specific to the blood program [25, 26]. Furthermore, an insertional mutagenesis screen was conducted by Nancy Hopkins and co-workers, in which a retrovirus was inserted into the genome to promote random mutagenesis [27, 28]. The recovered mutations defined 315 independent mutants affecting early development. In another study, retroviral insertions were shown to be highly efficient on a genome-wide scale, with nearly one in five integrations resulting in mutation . The mutants discovered in these large-scale screens have proved extremely useful, with some associated with cancer phenotypes and others affecting individual organs.
In the zebrafish system, haploid genetics can also be used [30–32]. This is extremely powerful as it reduces the extensive requirements typically associated with genetic screens. In a haploid screen, males are mutagenized (with ENU) and mated with a female. The eggs produced by the second-generation females are studied by in vitro fertilization with UV-irradiated sperm. The UV irradiation functionally inactivates the paternal DNA while maintaining sperm fertility, thus creating haploid animals. Zebrafish haploids typically survive for 4 days, but the reason for death is unclear. However, given that blood formation occurs within the first 36 hours of development, haploid screens can be used to study independent hematopoietic mutants. A recent variant of such a screen used early pressure to identify several mutants that affected T-cell development [20, 33]. The early pressure method suppresses the second meiotic division, generates gynogenetic diploids, and thus eliminates the additional complexity created by heterozygosity . Using this particular method, the sart3 gene was found to be critically required for thymus development through regulation of the U6 small nuclear ribonucleoprotein .
Morpholinos and gene knockdown
Morpholinos are small antisense oligonucleotides that are constructed to specifically target sequences at the transcriptional start site (ATG morpholinos) or at intron-exon splice junctions (splicing morpholinos) and allow selective inhibition of a target gene . The use of morpholinos has greatly expanded the versatility and importance of the zebrafish model in biomedical sciences [9, 36, 37].
Morpholinos have been used extensively for the knockdown of a variety of hematopoietic genes and have proven to be an important tool for genetic screens. For instance, we are currently conducting a chromatin factor screen, targeting over 480 independent factors via morpholino knockdown, to determine DNA rearrangement requirements in hematopoiesis. This screen provides a means for determining the role of chromatin factors in the birth of hematopoietic stem cells (HSCs) in the aorta and in globin expression (HT Huang, K Kathrein, and LI Zon, unpublished).
A new era of genetic suppressor screens
In another suppressor screen we analyzed the cdx4 mutant kgg, which is defective in HSC development because of abnormal hox gene expression [42, 43]. Several chemicals were found to rescue the cdx4 mutant, many of which are involved in the retinoic acid pathway. This suggests that the Cdx-Hox pathway mediates the retinoic acid response during hematopoietic cell development. Through these types of large-scale screens, the zebrafish model provides a means of defining connections between abnormal gene function and their respective pathways.
Small-molecule screens in the zebrafish
Many other small-molecule screens have been performed, contributing equally promising candidate chemical treatments. The discovery of 3F8, a novel inhibitor of glycogen synthase kinase 3 (Gsk3), has great potential as a candidate for therapeutic use. Gsk3 is a key member of the Wnt and hedgehog signaling pathways and has been linked to a number of human diseases, including type 2 diabetes, bipolar disorder, Alzheimer's disease, and some cancers . The combination of multiple pathway involvement and multiple disease implication makes Gsk3 a potentially important drug target. In a recent chemical screen of 4,000 compounds, 3F8 was found to phenocopy the 'no-eyes' embryonic zebrafish phenotype observed in cases of Wnt overexpression, as the result of Gsk3 inhibition . Subsequent analysis has shown 3F8 to be more selective and potent than the previously used GSK3 inhibitors, suggesting increased potential for research and clinical application .
These studies demonstrate the advantages provided by the zebrafish model as a platform for conducting large-scale screens for potential molecules that target stem cell development, hematopoietic differentiation, and disease-related mechanisms. Small-molecule screens have proven invaluable to the discovery and evaluation of chemicals displaying potential for clinical research and as reagents for translational research.
Hematopoiesis in the zebrafish and mammals
Hematopoietic stem cell development and emergence
The ontogeny of HSCs has been a major focus of research in the blood research community. Use of the cd41-GFP zebrafish transgenic line has shown that HSCs are first derived in the AGM region and are marked by CD41 positivity [55, 56]. Further analysis using the cd41-GFP line has led to the observation that CD41-positive cells exist in two distinct populations, which are manifested as GFP(hi) or GFP(lo) cells in this system . After sorting by flow cytometry, each CD41 population was evaluated for long-term engraftment and multilineage reconstitution in sublethally irradiated zebrafish. The resulting data indicate that cd41-GFP(lo) cells represent true HSCs, as these cells are capable of both engraftment and long-term sustainment of the hematopoietic program .
The origin of HSCs has long been an important topic in the hematopoietic field. However, recent advances in zebrafish live imaging technology have provided new insights into HSC emergence from the AGM region. Transgenic zebrafish with red-labeled endothelial cells and green-labeled blood cells have been used to directly visualize the budding process of HSCs from aorta endothelial cells [57–59]. Using the kdr-GFP transgenic zebrafish line, which drives GFP expression under the control of the kdrl gene promoter in vasculature starting at 18 hpf , time-lapse fluorescence confocal microscopy revealed endothelial cells emerging from the aortic floor and entering the sub-aortic space starting at 30 hpf, a process that has been termed endothelial hematopoietic transition (EHT) . The emergent kdr-GFP+ cells are morphologically consistent with hematopoietic progenitor cells and are shown to seed the CHT (35 hpf) and thymus (3 dpf). runx1 morpholino knockdown in the kdr-GFP line has also demonstrated that the EHT event is a Runx1-dependent process, as the budding process does not occur in the absence of Runx1 [58, 59].
Visualization of HSCs in adult zebrafish had been difficult until the recent development of an adult transplant zebrafish model called Casper . The Casper line lacks pigmentation, which allows individual cell visualization in transplants of fluorescent marrow. This provides an adult fate mapping and imaging model that can be used to analyze kidney colonization and development.
Fate mapping in the zebrafish
One of the greatest attributes of the zebrafish model is the ability to trace hematopoietic cell fate as differentiation occurs in the embryo. Caged fluorescein dye, which changes color in response to a laser pulse, can be injected into embryos [61–63]. Laser activation of single cells, or groups of cells, allows the tracking of individual cell derivation over time. This technique has been particularly useful in the study of HSC development within the aorta. 'Uncaged' HSCs were followed as they colonized the CHT. The cells arising from the CHT then seeded the thymus and the kidney . In zebrafish, the kidney serves as the primary site of larval and adult hematopoiesis . Analysis of fluorescently labeled, mutant, or morphant (morpholino knockdown) cells has enabled the investigation of cell migration and development. This has led to the discovery of chemokine receptors that are responsible for thymus colonization in the zebrafish . In addition, fate mapping can now make use of transgenic zebrafish containing a Cre-Ert2 (mutated estrogen receptor) construct that, when initiated, switches the expression of an integrated construct from the green label GFP to the red label DsRed in specific cells or tissues . The progeny of these switched cells maintain DsRed expression and are easily traced through development. These studies have enabled visualization of the hematopoietic system at significant resolution and have been extremely useful for defining the sites of zebrafish hematopoiesis.
In the zebrafish, blastula transplantation provides a model for examining cell autonomy in many cell types, including HSCs . Mutant or morphant cells are injected with a fluorescent dye and then transplanted into a wild-type embryo or vice versa . The implanted cells are tracked using their fluorescence. Transplantation of a fluorescent mutant cell that results in the lack of fluorescent blood indicates that the gene acted in a cell-autonomous manner. More recently, this technique has been improved to allow transplantation of blastula cells from a myb-GFP donor. This transgenic line contains a BAC expressing GFP under the control of a myb promoter, which marks donor cells as they form HSCs in the dorsal aorta . These cells are then injected into a recipient containing a red fluorescent protein (RFP) construct that labels the vasculature red. The derivation of green cells adjacent to the red endothelial cells indicates autonomous effects of stem cell production. These techniques allow the tracking of individual cells, which is very informative in the study of such a dynamic system.
Blood diseases in zebrafish
The zebrafish model has been used in the discovery of many new compounds with potential for clinical and therapeutic applications (Table 2), including several zebrafish cancer models that have been introduced over the past few years. These models are generally easy to manipulate and study while showing high genetic similarity to human cancer lines . One such model uses a conditional Cre/lox-regulated system under the control of a heat shock promoter that drives rag2 expression in developing T cells [70, 71]. Several recent publications have investigated this system in the study of T-ALL and cancer biology. A recent T-ALL study found that high levels of the apoptosis regulator Bcl2, the G-coupled protein receptor S1p1, and the cell adhesion protein Icam1 blocked tumor cell intravasation, an important initial step in metastasis . In addition, results obtained using the zebrafish model have allowed the differences between human T-cell lymphoblastic lymphoma (T-LBL) and human T-ALL to be defined according to their cellular and molecular components. Currently, human T-LBL and T-ALL are treated with the same regimens; however, these data have demonstrated key molecular differences that could allow more targeted treatments in the future .
The characterization of the ferroportin gene by zebrafish gene cloning is a prime example of the relevance of the zebrafish model for the discovery of disease-related genes . Ferroportin was mutated in the weissherbst mutant and, using this model, was found to be the iron transporter responsible for delivering maternally derived iron from the yolk to the embryo. Human placental cells have since been found to express ferroportin . Thus, maternal iron delivery to the fetus by ferroportin has been evolutionarily conserved for 300 million years. Furthermore, anemia of chronic disease has been linked to this gene through the ligand hepcidin, which binds ferroportin and promotes its internalization. Dysregulation of this pathway can lead to hemochromatosis, an iron imbalance disorder . Ferroportin mutations have been found in several patients with hemochromatosis, and this illustrates how studies of a zebrafish mutant have contributed to the definition of a human disease. More recently, mitoferrin and glutaredoxin 5 have also been linked to iron defects.
Since its discovery as an enhancer of HSC development in zebrafish, dmPGE2 is advancing towards clinical use. A clinical trial is currently analyzing dmPGE2 and its potential for enhancing engraftment in cord stem cell transplants. In that trial, leukemia or lymphoma patients are recruited and treated with high-dose chemotherapy before being transplanted with two independent cord blood samples. One of the cords is pretreated with dmPGE2, and following transplantation the level of chimerism is evaluated to determine which is the dominant cord. Thus, the trial will investigate whether dmPGE2-stimulated cells might display better engraftment capability over time, a result that could greatly increase the efficacy of cord blood and bone marrow transplantation in humans.
Lessons from the zebrafish model
Through mass mating procedures, the zebrafish can be used in various high-throughput genomic techniques that have not been possible with other vertebrate models. The advantages provided by the zebrafish in visualization, fate mapping, and early embryonic development contribute greatly to cell biological studies, particularly as they pertain to early hematopoietic development and HSCs. In addition, mutagenesis, chemical, and other large-scale screens are important methods for the discovery of novel pathways and potential therapeutics targeting hematopoiesis.
As mentioned, transplantation assays have also been developed in the zebrafish [75, 76]. The first marrow transplants were performed using GFP-positive whole kidney marrow transplanted into irradiated adults. GFP-positive blood cells can be seen in the host up to 6 months after transplantation. Serial transplantation has also demonstrated effectiveness, as recipients retain GFP-positive blood for months after transplant. More recently, competitive repopulation studies between red and green fluorescently tagged marrow cells have been performed in the Casper line, in which marrow cells are pretreated with a chemical and evaluated for competitive advantage . Through the use of this technology, chemicals can be screened to assess their ability to enhance transplantation, and thus to enhance the robustness of HSC development, engraftment, and retention.
Implications for translational stem cell research
Recent advances in epigenetic and sequencing technologies, particularly the development of ChIP-seq and RNA-seq, have allowed the investigation of molecular interactions on a genome-wide scale . Recently, the genome-wide binding sites of the essential hematopoietic transcription factors Gata1, Gata2, Runx1, Fli1, and Scl in human megakaryocytes were identified . Analysis revealed 144 regions representing 151 candidate genes that showed simultaneous binding of all five factors. Of these genes, 18 had known functions in hematopoiesis, and the zebrafish model was then used to further investigate these genes. Eight genes were chosen at random and targeted for knockdown using morpholinos. In each case, morpholino injection caused a significant reduction in erythrocyte, thrombocyte, and/or HSC number. This study demonstrates the effectiveness of the zebrafish model in validating results found in other organisms using a high-throughput in vivo system .
The use of ChIP-seq analysis has also led to resolution of the molecular interplay among external signaling transcription factors and cell-specific regulators during hematopoietic regeneration. In a recent study using a combination of zebrafish, murine, and human inputs, the BMP and Wnt signaling pathways were shown to be essential for hematopoietic regeneration following acute hematopoietic injury . In this study, ChIP-seq analysis demonstrated that Smad1 and Tcf7l2 co-occupy sites with cell-specific master regulators in a dynamic manner throughout differentiation. These data suggest that the hematopoietic program is coordinated by a finely tuned collaboration between master regulators and external signaling factors, in which master regulators direct the binding profiles of the signaling transcription factors.
In addition to serving as an effective chemical screening platform, the zebrafish model has shown promise as an efficient means of prescreening small molecules for drug candidacy. A recent study evaluated the specificity of three molecules that are known to inhibit polo-like kinase 1 (Plk1) in vitro, a protein that is overexpressed in many tumors and thus is considered a potentially important target for cancer therapy . Analysis of Plk1 has revealed high conservation between the zebrafish and human homologs, including a nearly identical active site composition . The study investigated the Plk1 inhibitors LFM-A13, ON01910, and thiazole-carboxamide 10A to determine which molecule provided the most specific and effective inhibition in vivo. The embryonic phenotypes resulting from each chemical treatment were compared with the phenotype resulting from direct morpholino knockdown of Plk1. The results indicated that whereas each inhibitor showed promise in vitro, only one, thiazole-carboxamide 10A, selectively inhibited Plk1 in vivo. This result highlights the difficulty associated with the discovery of drug candidates through in vitro methods, as well as the significant advantage provided by using the zebrafish model to prescreen potential therapeutics in vivo .
Conclusions and future directions
The zebrafish model provides a tremendous balance between scale and applicability. The ease of mutagenesis, high fecundity, and visualization techniques, in conjunction with the largely conserved hematopoietic system that the zebrafish provides, allow large-scale genomic analysis while maintaining relevance in higher organisms. The definition of genes involved in T-ALL and hypochromic anemia, and the discovery and assessment of dmPGE2, thiazole-carboxamide 10A, and 3F8 have demonstrated the relevance of the zebrafish model for clinical and therapeutic research. This model will continue to help define genetic and epigenetic mechanisms in blood cells using the high-throughput procedures ChIP-seq, RNA-seq, and morpholino screening. Further studies of HSC development, self-renewal, and differentiation using the zebrafish model have great potential to contribute to advances in the treatment and management of numerous blood diseases and cancers.
aorta gonad mesonephros
bacterial artificial chromosome
chromatin immunoprecipitation sequencing
caudal hematopoietic tissue
dimethyl prostaglandin E2
DRB sensitivity-inducing factor
endothelial hematopoietic transition
green fluorescent protein
glycogen synthase kinase 3
hematopoietic stem cell
polo-like kinase 1
red fluorescent protein
T-cell acute lymphoblastic leukemia
T-cell lymphoblastic lymphoma.
We would like to thank Erin Langdon and Alison Taylor for help in the editing process, and Dorothy Giarla for organizational and submission assistance.
- Tamplin OJ, Zon LI: Blood flow: metalloproteases cut loose in primitive erythrocytes. Curr Biol. 2010, 20: R561-R562. 10.1016/j.cub.2010.05.014.PubMedView ArticleGoogle Scholar
- Bai X, Kim J, Yang Z, Jurynec MJ, Akie TE, Lee J, LeBlanc J, Sessa A, Jiang H, DiBiase A, Zhou Y, Grunwald DJ, Lin S, Cantor AB, Orkin SH, Zon LI: TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell. 2010, 142: 133-143. 10.1016/j.cell.2010.05.028.PubMedPubMed CentralView ArticleGoogle Scholar
- Granato M, van Eeden FJ, Schach U, Trowe T, Brand M, Furutani-Seiki M, Haffter P, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, Odenthal J, Nüsslein-Volhard C: Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development. 1996, 123: 399-413.PubMedGoogle Scholar
- Zon LI, Peterson RT: In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 2005, 4: 35-44. 10.1038/nrd1606.PubMedView ArticleGoogle Scholar
- Zhong H, Lin S: Chemical screening with zebrafish embryos. Methods Mol Biol. 2011, 716: 193-205. 10.1007/978-1-61779-012-6_12.PubMedView ArticleGoogle Scholar
- Hao J, Williams CH, Webb ME, Hong CC: Large scale zebrafish-based in vivo small molecule screen. J Vis Exp. 2010, pii:2243, 46Google Scholar
- Petzold AM, Balciunas D, Sivasubbu S, Clark KJ, Bedell VM, Westcot SE, Myers SR, Moulder GL, Thomas MJ, Ekker SC: Nicotine response genetics in the zebrafish. Proc Natl Acad Sci USA. 2009, 106: 18662-18667. 10.1073/pnas.0908247106.PubMedPubMed CentralView ArticleGoogle Scholar
- Kobayashi I, Ono H, Moritomo T, Kano K, Nakanishi T, Suda T: Comparative gene expression analysis of zebrafish and mammals identifies common regulators in hematopoietic stem cells. Blood. 2010, 115: e1-9. 10.1182/blood-2009-07-232322.PubMedView ArticleGoogle Scholar
- Nasevicius A, Ekker SC: Effective targeted gene 'knockdown' in zebrafish. Nat Genet. 2000, 26: 216-220. 10.1038/79951.PubMedView ArticleGoogle Scholar
- Clark MS: Genomics and mapping of teleostei (bony fish). Comp Funct Genomics. 2003, 4: 182-193. 10.1002/cfg.259.PubMedPubMed CentralView ArticleGoogle Scholar
- Catchen JM, Conery JS, Postlethwait JH: Automated identification of conserved synteny after whole-genome duplication. Genome Res. 2009, 19: 1497-1505. 10.1101/gr.090480.108.PubMedPubMed CentralView ArticleGoogle Scholar
- Jozefowicz C, McClintock J, Prince V: The fates of zebrafish Hox gene duplicates. J Struct Funct Genomics. 2003, 3: 185-194. 10.1023/A:1022690723661.PubMedView ArticleGoogle Scholar
- Wingert RA, Brownlie A, Galloway JL, Dooley K, Fraenkel P, Axe JL, Davidson AJ, Barut B, Noriega L, Sheng X, Zhou Y, Zon LI: The chianti zebrafish mutant provides a model for erythroid-specific disruption of transferrin receptor 1. Development. 2004, 131: 6225-6235. 10.1242/dev.01540.PubMedView ArticleGoogle Scholar
- Havis E, Anselme I, Schneider-Maunoury S: Whole embryo chromatin immunoprecipitation protocol for the in vivo study of zebrafish development. Biotechniques. 2006, 40: 34, 36, 38 passimGoogle Scholar
- Lindeman LC, Vogt-Kielland LT, Aleström P, Collas P: Fish'n ChIPs: chromatin immunoprecipitation in the zebrafish embryo. Methods Mol Biol. 2009, 567: 75-86. 10.1007/978-1-60327-414-2_5.PubMedView ArticleGoogle Scholar
- Vastenhouw NL, Zhang Y, Woods IG, Imam F, Regev A, Liu XS, Rinn J, Schier AF: Chromatin signature of embryonic pluripotency is established during genome activation. Nature. 2010, 464: 922-926. 10.1038/nature08866.PubMedPubMed CentralView ArticleGoogle Scholar
- Lindeman LC, Winata CL, Aanes H, Mathavan S, Alestrom P, Collas P: Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos. Int J Dev Biol. 2010, 54: 803-813. 10.1387/ijdb.103081ll.PubMedView ArticleGoogle Scholar
- Weinstein BM, Schier AF, Abdelilah S, Malicki J, Solnica-Krezel L, Stemple DL, Stainier DY, Zwartkruis F, Driever W, Fishman MC: Hematopoietic mutations in the zebrafish. Development. 1996, 123: 303-309.PubMedGoogle Scholar
- Ransom DG, Haffter P, Odenthal J, Brownlie A, Vogelsang E, Kelsh RN, Brand M, van Eeden FJ, Furutani-Seiki M, Granato M, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Mullins MC, Nüsslein-Volhard C: Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development. 1996, 123: 311-319.PubMedGoogle Scholar
- Trede NS, Ota T, Kawasaki H, Paw BH, Katz T, Demarest B, Hutchinson S, Zhou Y, Hersey C, Zapata A, Amemiya CT, Zon LI: Zebrafish mutants with disrupted early T-cell and thymus development identified in early pressure screen. Dev Dyn. 2008, 237: 2575-2584. 10.1002/dvdy.21683.PubMedPubMed CentralView ArticleGoogle Scholar
- Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000, 403: 776-781. 10.1038/35001596.PubMedView ArticleGoogle Scholar
- Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, Gwynn B, Lambert AJ, Wingert RA, Traver D, Trede NS, Barut BA, Zhou Y, Minet E, Donovan A, Brownlie A, Balzan R, Weiss MJ, Peters LL, Kaplan J, Zon LI, Paw BH: Mitoferrin is essential for erythroid iron assimilation. Nature. 2006, 440: 96-100. 10.1038/nature04512.PubMedView ArticleGoogle Scholar
- Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Schmidt B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, Zon LI: Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005, 436: 1035-1039. 10.1038/nature03887.PubMedView ArticleGoogle Scholar
- Moens CB, Donn TM, Wolf-Saxon ER, Ma TP: Reverse genetics in zebrafish by TILLING. Brief Funct Genomic Proteomic. 2008, 7: 454-459. 10.1093/bfgp/eln046.PubMedPubMed CentralView ArticleGoogle Scholar
- Sood R, English MA, Belele CL, Jin H, Bishop K, Haskins R, McKinney MC, Chahal J, Weinstein BM, Wen Z, Liu PP: Development of multilineage adult hematopoiesis in the zebrafish with a runx1 truncation mutation. Blood. 2010, 115: 2806-2809. 10.1182/blood-2009-08-236729.PubMedPubMed CentralView ArticleGoogle Scholar
- Belele CL, English MA, Chahal J, Burnetti A, Finckbeiner SM, Gibney G, Kirby M, Sood R, Liu PP: Differential requirement for Gata1 DNA binding and transactivation between primitive and definitive stages of hematopoiesis in zebrafish. Blood. 2009, 114: 5162-5172. 10.1182/blood-2009-05-224709.PubMedPubMed CentralView ArticleGoogle Scholar
- Amsterdam A, Burgess S, Golling G, Chen W, Sun Z, Townsend K, Farrington S, Haldi M, Hopkins N: A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 1999, 13: 2713-2724. 10.1101/gad.13.20.2713.PubMedPubMed CentralView ArticleGoogle Scholar
- Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N: Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA. 2004, 101: 12792-12797. 10.1073/pnas.0403929101.PubMedPubMed CentralView ArticleGoogle Scholar
- Wang D, Jao LE, Zheng N, Dolan K, Ivey J, Zonies S, Wu X, Wu K, Yang H, Meng Q, Zhu Z, Zhang B, Lin S, Burgess SM: Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions. Proc Natl Acad Sci USA. 2007, 104: 12428-33. 10.1073/pnas.0705502104.PubMedPubMed CentralView ArticleGoogle Scholar
- Cheng KC, Moore JL: Genetic dissection of vertebrate processes in the zebrafish: a comparison of uniparental and two-generation screens. Biochem Cell Biol. 1997, 75: 525-533. 10.1139/o97-087.PubMedView ArticleGoogle Scholar
- Layton JE: Undertaking a successful gynogenetic haploid screen in zebrafish. Methods Mol Biol. 2009, 546: 31-44. 10.1007/978-1-60327-977-2_3.PubMedView ArticleGoogle Scholar
- Walker C: Haploid screens and gamma-ray mutagenesis. Methods Cell Biol. 1999, 60: 43-70.PubMedView ArticleGoogle Scholar
- Frazer JK, Meeker ND, Rudner L, Bradley DF, Smith AC, Demarest B, Joshi D, Locke EE, Hutchinson SA, Tripp S, Perkins SL, Trede NS: Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia. 2009, 23: 1825-1835. 10.1038/leu.2009.116.PubMedPubMed CentralView ArticleGoogle Scholar
- Walker C, Walsh GS, Moens C: Making gynogenetic diploid zebrafish by early pressure. J Vis Exp. 2009, pii:1396, 28Google Scholar
- Trede NS, Medenbach J, Damianov A, Hung LH, Weber GJ, Paw BH, Zhou Y, Hersey C, Zapata A, Keefe M, Barut BA, Stuart AB, Katz T, Amemiya CT, Zon LI, Bindereif A: Network of coregulated spliceosome components revealed by zebrafish mutant in recycling factor p110. Proc Natl Acad Sci USA. 2007, 104: 6608-6613. 10.1073/pnas.0701919104.PubMedPubMed CentralView ArticleGoogle Scholar
- Bill BR, Petzold AM, Clark KJ, Schimmenti LA, Ekker SC: A primer for morpholino use in zebrafish. Zebrafish. 2009, 6: 69-77. 10.1089/zeb.2008.0555.PubMedPubMed CentralView ArticleGoogle Scholar
- Yuan S, Sun Z: Microinjection of mRNA and morpholino antisense oligonucleotides in zebrafish embryos. J Vis Exp. 2009, pii:1113, 27Google Scholar
- Ransom DG, Bahary N, Niss K, Traver D, Burns C, Trede NS, Paffett-Lugassy N, Saganic WJ, Lim CA, Hersey C, Zhou Y, Barut BA, Lin S, Kingsley PD, Palis J, Orkin SH, Zon LI: The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis. PLoS Biol. 2004, 2: E237-10.1371/journal.pbio.0020237.PubMedPubMed CentralView ArticleGoogle Scholar
- He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J: Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell. 2006, 125: 929-941. 10.1016/j.cell.2006.03.045.PubMedView ArticleGoogle Scholar
- Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, Inui M, Moro S, Modena N, Argenton F, Newfeld SJ, Piccolo S: FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell. 2009, 136: 123-135. 10.1016/j.cell.2008.10.051.PubMedView ArticleGoogle Scholar
- White RM, Cech J, Ratanasirintrawoot S, Lin CY, Rahl PB, Burke CJ, Langdon E, Tomlinson ML, Mosher J, Kaufman C, Chen F, Long HK, Kramer M, Datta S, Neuberg D, Granter S, Young RA, Morrison S, Wheeler GN, Zon LI: DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature. 2011, 471: 518-522. 10.1038/nature09882.PubMedPubMed CentralView ArticleGoogle Scholar
- Davidson AJ, Ernst P, Wang Y, Dekens MP, Kingsley PD, Palis J, Korsmeyer SJ, Daley GQ, Zon LI: Cdx4 mutants fail to specify blood progenitors and can be rescued by multiple Hox genes. Nature. 2003, 425: 300-306. 10.1038/nature01973.PubMedView ArticleGoogle Scholar
- Paik EJ, de Jong JL, Pugach E, Opara P, Zon LI: A chemical genetic screen in zebrafish for pathways interacting with cdx4 in primitive hematopoiesis. Zebrafish. 2010, 7: 6168-View ArticleGoogle Scholar
- Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, Macrae CA, Shoichet B, Peterson RT: Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol. 2010, 6: 231-237. 10.1038/nchembio.307.PubMedPubMed CentralView ArticleGoogle Scholar
- North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH, Grosser T, Fitzgerald GA, Daley GQ, Orkin SH, Zon LI: Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007, 447: 1007-1011. 10.1038/nature05883.PubMedPubMed CentralView ArticleGoogle Scholar
- Goessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey M, Harris JM, Metzger ME, Bonifacino AC, Stroncek D, Stegner J, Armant M, Schlaeger T, Tisdale JF, Zon LI, Donahue RE, North TE: Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell. 2011, 8: 445-458. 10.1016/j.stem.2011.02.003.PubMedPubMed CentralView ArticleGoogle Scholar
- Meijer L, Flajolet M, Greengard P: Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci. 2004, 25: 471-480. 10.1016/j.tips.2004.07.006.PubMedView ArticleGoogle Scholar
- Zhong H, Zou H, Semenov MV, Moshinsky D, He X, Huang H, Li S, Quan J, Yang Z, Lin S: Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling. Mol Biosyst. 2009, 5: 1356-1360. 10.1039/b905752h.PubMedPubMed CentralView ArticleGoogle Scholar
- Paik EJ, Zon LI: Hematopoietic development in the zebrafish. Int J Dev Biol. 2010, 54: 1127-1137. 10.1387/ijdb.093042ep.PubMedView ArticleGoogle Scholar
- de Jong JL, Zon LI: Use of the zebrafish system to study primitive and definitive hematopoiesis. Annu Rev Genet. 2005, 39: 481-501. 10.1146/annurev.genet.39.073003.095931.PubMedView ArticleGoogle Scholar
- Priddle H, Jones DR, Burridge PW, Patient R: Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies. Stem Cells. 2006, 24: 815-824. 10.1634/stemcells.2005-0356.PubMedView ArticleGoogle Scholar
- Chen AT, Zon LI: Zebrafish blood stem cells. J Cell Biochem. 2009, 108: 35-42. 10.1002/jcb.22251.PubMedView ArticleGoogle Scholar
- McGrath KE, Palis J: Hematopoiesis in the yolk sac: more than meets the eye. Exp Hematol. 2005, 33: 1021-1028. 10.1016/j.exphem.2005.06.012.PubMedView ArticleGoogle Scholar
- Labastie MC, Cortés F, Roméo PH, Dulac C, Péault B: Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood. 1998, 92: 3624-3635.PubMedGoogle Scholar
- Lin HF, Traver D, Zhu H, Dooley K, Paw BH, Zon LI, Handin RI: Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood. 2005, 106: 3803-3810. 10.1182/blood-2005-01-0179.PubMedPubMed CentralView ArticleGoogle Scholar
- Ma D, Zhang J, Lin HF, Italiano J, Handin RI: The identification and characterization of zebrafish hematopoietic stem cells. Blood. 2011, 118: 289-297. 10.1182/blood-2010-12-327403.PubMedPubMed CentralView ArticleGoogle Scholar
- Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY, Traver D: Haematopoietic stem cells derive directly from aortic endothelium during development. Nature. 2010, 464: 108-111. 10.1038/nature08738.PubMedPubMed CentralView ArticleGoogle Scholar
- Lam EY, Hall CJ, Crosier PS, Crosier KE, Flores MV: Live imaging of Runx1 expression in the dorsal aorta tracks the emergence of blood progenitors from endothelial cells. Blood. 2010, 116: 909-914. 10.1182/blood-2010-01-264382.PubMedView ArticleGoogle Scholar
- Kissa K, Herbomel P: Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature. 2010, 464: 112-115. 10.1038/nature08761.PubMedView ArticleGoogle Scholar
- White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, Zon LI: Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008, 2: 183-189. 10.1016/j.stem.2007.11.002.PubMedPubMed CentralView ArticleGoogle Scholar
- Russek-Blum N, Nabel-Rosen H, Levkowitz G: Two-photon-based photoactivation in live zebrafish embryos. J Vis Exp. 2010, pii:1902, 46Google Scholar
- Kobayashi T, Urano Y, Kamiya M, Ueno T, Kojima H, Nagano T: Highly activatable and rapidly releasable caged fluorescein derivatives. J Am Chem Soc. 2007, 129: 6696-6697. 10.1021/ja070376d.PubMedView ArticleGoogle Scholar
- Braun KL, Hapuarachchi S, Fernandez FM, Aspinwall CA: High-sensitivity detection of biological amines using fast Hadamard transform CE coupled with photolytic optical gating. Electrophoresis. 2007, 28: 3115-3121. 10.1002/elps.200700087.PubMedView ArticleGoogle Scholar
- Murayama E, Kissa K, Zapata A, Mordelet E, Briolat V, Lin HF, Handin RI, Herbomel P: Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development. Immunity. 2006, 25: 963-975. 10.1016/j.immuni.2006.10.015.PubMedView ArticleGoogle Scholar
- Bajoghli B, Aghaallaei N, Hess I, Rode I, Netuschil N, Tay BH, Venkatesh B, Yu JK, Kaltenbach SL, Holland ND, Diekhoff D, Happe C, Schorpp M, Boehm T: Evolution of genetic networks underlying the emergence of thymopoiesis in vertebrates. Cell. 2009, 138: 186-197. 10.1016/j.cell.2009.04.017.PubMedView ArticleGoogle Scholar
- Mosimann C, Kaufman CK, Li P, Pugach EK, Tamplin OJ, Zon LI: Ubiquitous transgene expression and Cre-based recombination driven by the ubiquitin promoter in zebrafish. Development. 2011, 138: 169-177. 10.1242/dev.059345.PubMedPubMed CentralView ArticleGoogle Scholar
- Goessling W, North TE, Lord AM, Ceol C, Lee S, Weidinger G, Bourque C, Strijbosch R, Haramis AP, Puder M, Clevers H, Moon RT, Zon LI: APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development. Dev Biol. 2008, 320: 161-174. 10.1016/j.ydbio.2008.05.526.PubMedView ArticleGoogle Scholar
- Kemp HA, Carmany-Rampey A, Moens C: Generating chimeric zebrafish embryos by transplantation. J Vis Exp. 2009, pii:1394, 29Google Scholar
- Etchin J, Kanki JP, Look AT: Zebrafish as a model for the study of human cancer. Methods Cell Biol. 2011, 105: 309-337.PubMedView ArticleGoogle Scholar
- Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, Lin S, Prochownik E, Trede NS, Zon LI, Look AT: Myc-induced T cell leukemia in transgenic zebrafish. Science. 2003, 299: 887-890. 10.1126/science.1080280.PubMedView ArticleGoogle Scholar
- Feng H, Langenau DM, Madge JA, Quinkertz A, Gutierrez A, Neuberg DS, Kanki JP, Look AT: Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish. Br J Haematol. 2007, 138: 169-175. 10.1111/j.1365-2141.2007.06625.x.PubMedView ArticleGoogle Scholar
- Feng H, Stachura DL, White RM, Gutierrez A, Zhang L, Sanda T, Jette CA, Testa JR, Neuberg DS, Langenau DM, Kutok JL, Zon LI, Traver D, Fleming MD, Kanki JP, Look AT: T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell. 2010, 18: 353-366. 10.1016/j.ccr.2010.09.009.PubMedPubMed CentralView ArticleGoogle Scholar
- Bastin J, Drakesmith H, Rees M, Sargent I, Townsend A: Localisation of proteins of iron metabolism in the human placenta and liver. Br J Haematol. 2006, 134: 532-543. 10.1111/j.1365-2141.2006.06216.x.PubMedView ArticleGoogle Scholar
- Ganz T: Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program. 2006: 29-35. 507
- Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI: Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol. 2003, 4: 1238-1246. 10.1038/ni1007.PubMedView ArticleGoogle Scholar
- Traver D, Winzeler A, Stern HM, Mayhall EA, Langenau DM, Kutok JL, Look AT, Zon LI: Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood. 2004, 104: 1298-1305. 10.1182/blood-2004-01-0100.PubMedView ArticleGoogle Scholar
- Wilson NK, Tijssen MR, Göttgens B: Deciphering transcriptional control mechanisms in hematopoiesis:the impact of high-throughput sequencing technologies. Exp Hematol. 2011, 39: 961-968. 10.1016/j.exphem.2011.07.005.PubMedView ArticleGoogle Scholar
- Tijssen MR, Cvejic A, Joshi A, Hannah RL, Ferreira R, Forrai A, Bellissimo DC, Oram SH, Smethurst PA, Wilson NK, Wang X, Ottersbach K, Stemple DL, Green AR, Ouwehand WH, Göttgens B: Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011, 20: 597-609. 10.1016/j.devcel.2011.04.008.PubMedPubMed CentralView ArticleGoogle Scholar
- Trompouki E, Bowman TV, Lawton LN, Fan ZP, Wu DC, DiBiase A, Martin CS, Cech JN, Sessa AK, Leblanc JL, Li P, Durand EM, Mosimann C, Heffner GC, Daley GQ, Paulson RF, Young RA, Zon LI: Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell. 2011, 147: 577-589. 10.1016/j.cell.2011.09.044.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhong H, Xin S, Zhao Y, Lu J, Li S, Gong J, Yang Z, Lin S: Genetic approach to evaluate specificity of small molecule drug candidates inhibiting PLK1 using zebrafish. Mol Biosyst. 2010, 6: 1463-1468. 10.1039/b919743e.PubMedView ArticleGoogle Scholar
- Elling RA, Fucini RV, Romanowski MJ: Structures of the wild-type and activated catalytic domains of Brachydanio rerio Polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands. Acta Crystallogr D Biol Crystallogr. 2008, 64: 909-918. 10.1107/S0907444908019513.PubMedView ArticleGoogle Scholar